iShares LifePath Target Date 2050 ETF
ITDF
2 hedge funds and large institutions have $5.11K invested in iShares LifePath Target Date 2050 ETF in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
2.98% less ownership
Funds ownership: 3.01% → 0.03% (-3%)
99% less capital invested
Capital invested by funds: $344K → $5.11K (-$339K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.94K |
| 2 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$616 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$344K |
ITDF Hedge Fund Activity: Q3 2024 in Review
2 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in iShares LifePath Target Date 2050 ETF (ITDF) for Q3 2024, worth a combined $5.11K — down 99% from $344K a quarter earlier.
Fund positioning in ITDF was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $3.94K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $344K sold.
- 2 institutional investors held iShares LifePath Target Date 2050 ETF (ITDF) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $5.11K of iShares LifePath Target Date 2050 ETF stock for Q3 2024, down 99% quarter-over-quarter.
- 1 fund opened new iShares LifePath Target Date 2050 ETF positions in Q3 2024 and 1 closed out, a net change of 0 holders.
- The largest iShares LifePath Target Date 2050 ETF buyer in Q3 2024 was UBS Group, an estimated $3.94K added.
- The largest iShares LifePath Target Date 2050 ETF seller in Q3 2024 was Susquehanna International Group, an estimated $344K sold.
Based on aggregated 13F filings for Q3 2024.